Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010;74(3):510-9.
doi: 10.1271/bbb.90707. Epub 2010 Mar 7.

Study on the Postprandial Blood Glucose Suppression Effect of D-psicose in Borderline Diabetes and the Safety of Long-Term Ingestion by Normal Human Subjects

Affiliations
Free article
Randomized Controlled Trial

Study on the Postprandial Blood Glucose Suppression Effect of D-psicose in Borderline Diabetes and the Safety of Long-Term Ingestion by Normal Human Subjects

Noriko Hayashi et al. Biosci Biotechnol Biochem. .
Free article

Abstract

This clinical study was conducted to investigate the safety and effect of D-psicose on postprandial blood glucose levels in adult men and women, including borderline diabetes patients. A randomized double-blind placebo-controlled crossover experiment of single ingestion was conducted on 26 subjects who consumed zero or 5 g of D-psicose in tea with a standard meal. The blood glucose levels at fasting and 30, 60, 90, and 120 min after the meal were compared. The blood glucose level was significantly lower 30 and 60 min after the meal with D-psicose (p<0.01, p<0.05), and a significant decrease was also shown in the area under the curve (p<0.01). The results suggest that D-psicose had an effect to suppress the postprandial blood glucose elevation mainly in borderline diabetes cases. A randomized double-blind placebo-controlled parallel-group experiment of long-term ingestion was conducted on 17 normal subjects who took 5 g of D-psicose or D-glucose with meals three times a day for 12 continuous weeks. Neither any abnormal effects nor clinical problems caused by the continuous ingestion of D-psicose were found.

Similar articles

See all similar articles

Cited by 18 articles

See all "Cited by" articles

Publication types

Feedback